All posts tagged Korea pharmaceutical
Nichi-Iko acquires Aprogen stake
Aprogen, a subsidiary of the listed South Korean company Schnell Pharma, has confirmed its 33.4% stake is to be acquired by Nichi-Iko Pharmaceutical, Money Today reported. Nichi-Iko Pharmaceutical is the listed Japan-based drug company.
The report cited Aprogen and CEO Kim …
Global pharma eyeing Korean acquisitions as nation becomes test-bed
Two thousand and nine was a bumper year for global pharmaceutical M&A, with drug makers’ deals amounting to U$147.2 billion, including Pfizer’s U$68 billion deal for Wyeth and
Global Bio & Medical Forum 2010
The Global Bio & Medical Forum (GBF 2010) looks set to continue its tradition of providing international medical, biotech and pharmaceutical companies with high caliber partnering opportunities in Korea. The
Choseon Pharm & Trading open to bidding proposals
Choseon Pharm & Trading, an unlisted South Korea-based pharmaceutical company, is currently up for sale after it entered into court-supervised bankruptcy protection in August 2009. According to
Novartis Korea CEO: Korea key emerging pharmaceutical market
The Novartis Korea CEO, listed government support, growing per-capita consumption, and an aging population, as the key drivers of Korea's bio-pharmaceutical industry, in a recent interview with the JoongAng
